Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

"Medtronic’s Aurora EV-ICD to challenge Boston Scientific’s S-ICD market leadership" was originally created and published by ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Technological advancements in devices such as hearing aids, cochlear implants, and endoscopes are improving patient outcomes and broadening the scope of ENT specialists. This growth presents new ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

ADAPT-PD is a randomized crossover study that has enrolled 68 patients implanted with Medtronic’s Percept PC neurostimulator ...

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

A wireless pacemaker that is only the size of a capsule attracted exhibitors and visitors at the ongoing 2024 China International Fair for Trade in Services (Ciftis). The pacemaker's developer, ...

In July 2022, B. Braun Medical Inc. (B. Braun), has launched its new Introcan Safety 2 IV Catheter with one-time blood control. The Introcan Safety 2 IV Catheter is the latest development from B.